Does mild paravalvular regurgitation post transcatheter aortic valve implantation affect survival? A meta-analysis

Tomo Ando1,2, Alexandros Briasoulis3, Tesfaye Telila1

  • 1Division of Cardiology, Wayne State University, Harper Hospital, Detroit, Michigan.

Abstract

Insights

Mild paravalvular regurgitation (PVR) after transcatheter aortic valve implantation (TAVI) is linked to increased mortality. This meta-analysis confirms that even mild PVR significantly impacts patient survival outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Biostatistics

Background:

  • Mild paravalvular regurgitation (PVR) is a common complication following transcatheter aortic valve implantation (TAVI).
  • The clinical significance of mild PVR remains debated, despite advancements in prosthetic valve technology.
  • Existing data on mild PVR's impact on mortality are inconsistent, necessitating further investigation.

Purpose of the Study:

  • To quantitatively assess the association between mild PVR after TAVI and patient mortality.
  • To synthesize evidence from multiple studies to determine the clinical impact of mild PVR.
  • To provide a clearer understanding of the prognostic implications of mild PVR post-TAVI.

Main Methods:

  • A systematic literature search was performed using PubMed and Embase databases.
  • Meta-analysis included 25 studies with 21,018 patients, focusing on hazard ratios for all-cause and cardiac mortality.
  • Random-effects models were employed to pool data and assess heterogeneity and publication bias.

Main Results:

  • Mild PVR was associated with a significant increase in all-cause mortality (HR 1.26, 95% CI 1.11-1.43).
  • Cardiovascular mortality was also elevated in patients with mild PVR compared to those with none/trivial PVR (HR 1.28, 95% CI 1.05-1.57).
  • Significant heterogeneity was observed across studies for all-cause mortality, but not for cardiovascular mortality.

Conclusions:

  • Mild PVR following TAVI is a significant predictor of increased all-cause and cardiovascular mortality.
  • The findings underscore the importance of monitoring patients with mild PVR post-TAVI.
  • Further research is needed to determine if interventions for mild PVR can improve clinical outcomes.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
493
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
635
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
807
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
417
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
345
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
402